Monopar Therapeutics, Inc. (MNPR)
51.08
-2.39
(-4.47%)
USD |
NASDAQ |
Mar 03, 10:57
Monopar Therapeutics EPS Diluted (Quarterly) : -0.4826 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
| GB Sciences, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.438M |
| Total Expenses (Quarterly) | 3.438M |
| Enterprise Value | 213.71M |
| Earnings Yield | -6.73% |
| Normalized Earnings Yield | -6.732 |